Aclaris Therapeutics Inc (ACRS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ACRS? Forum Prognose

Finanzdaten der Aclaris Therapeutics Inc-Aktie (ACRS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	60.75% 1.295	3.299	1.777	1.455	9.211
Cost Of Revenue	1.12% 0.532	0.538	0.515	0.506	0.705
Gross Profit	72.37% 0.763	2.761	1.262	0.949	8.506
Operating Expenses	18.02% 23.50	19.91	19.67	19.03	108.18
Benefits Costs and Expenses	17.74% 21.09	17.91	17.21	16.54	105.76
Costs And Expenses	17.51% 24.03	20.45	20.18	19.54	108.89
Operating Income/Loss	32.57% -22.73	-17.15	-18.41	-18.08	-99.67
Nonoperating Income/Loss	15.94% 2.939	2.535	2.979	2.999	3.123
Income/Loss From Continuing Operations Before Tax	35.45% -19.80	-14.61	-15.43	-15.09	-96.55
Income/Loss From Continuing Operations After Tax	35.45% -19.80	-14.61	-15.43	-15.09	-96.55
Net Income/Loss	35.45% -19.80	-14.61	-15.43	-15.09	-96.55
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.97% 0.0337	122.62	122.58	122.39	6.0469
Diluted Average Shares	99.97% 0.0337	122.62	122.58	122.39	6.0469
Basic Earnings Per Share	33.33% -0.16	-0.12	-0.13	-0.12	-1.21
Diluted Earnings Per Share	33.33% -0.16	-0.12	-0.13	-0.12	-1.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%